PHusis Delivers Precision Medicines for the Treatment of Cancer
PHusis Therapeutics is developing novel targeted small molecule therapeutics that bind and block the pleckstrin homology (PH)-domain of critical signaling proteins involved in driving cancer cell growth and survival in patients with limited treatment options.
 |
 |
 |
|
 |